Johnson & Johnson Said to Plan $3.25 Billion Bond Offering

Deal would be the first for the company since May 2011.

Johnson & Johnson, the AAA rated maker of health-care products, is planning to sell $3.25 billion of debt in its first offering in more than two years.

The company, one of four U.S. nonfinancial borrowers with a top credit ranking, may sell six portions of bonds maturing in three to 30 years as soon as today, according to a person with knowledge of the transaction. The deal, its first since May 2011, will be used to repay existing debt.

The world’s largest maker of health-care products may sell $400 million of bonds maturing in three years to yield 18 basis points more than similar-maturity Treasuries, $600 million of five-year debt at a relative yield of 28 basis points, $550 million of 10-year securities at a 58 basis-point spread, $650 million of 20-year bonds at 55 basis points, and $500 million of 30-year debt at 65 basis points, said the person, who asked not to be identified because terms aren’t set. It may also issue $550 million of three-year, floating-rate notes to yield 7 basis points more than the three-month London interbank offered rate.

The debt is expected to be rated Aaa, the highest level of investment grade, by Moody’s Investors Service, and an equivalent AAA at Standard & Poor’s, the person said. Bank of America Corp., Goldman Sachs Group Inc., and JPMorgan Chase & Co. are managing the offering for the New Brunswick, New Jersey-based company.

Johnson & Johnson, along with Microsoft Corp., Exxon Mobil Corp., and Automatic Data Processing Inc., have the highest ratings from Moody’s and S&P. Microsoft raised $2.67 billion in April, including $1 billion of 10-year notes that yielded 3.49 percent on Nov. 25, according to data compiled by Bloomberg.

Copyright 2014 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Comments